| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 2024.13 | 98 |
| GSM780708 | Untreated after 4 days (C2_1) | 2142.12 | 98 |
| GSM780709 | Untreated after 4 days (C3_1) | 2259.41 | 98 |
| GSM780719 | Untreated after 4 days (C1_2) | 2013.64 | 98 |
| GSM780720 | Untreated after 4 days (C2_2) | 2053.19 | 98 |
| GSM780721 | Untreated after 4 days (C3_2) | 2007.04 | 98 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 2230.18 | 98 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 1778.41 | 98 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 1564.92 | 97 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 1805.54 | 98 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 2027.73 | 98 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 1533.85 | 97 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 1863.84 | 98 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 2286.22 | 98 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 2255.13 | 98 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 1831.74 | 98 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 1967.51 | 98 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 2000.65 | 98 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 2038.27 | 98 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 1817.68 | 98 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 1750.07 | 98 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 1637 | 97 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 1615.8 | 97 |